Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients
Sponsor: CareDx
This observational or N/A phase trial investigates Kidney Transplant Rejection and Pancreas Transplant Rejection and is currently completed. CareDx leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2022 — Jan 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — May 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2020 — Apr 2020 [monthly]
Not Yet Recruiting
-
Nov 2019 — Jan 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CareDx
- Rush University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .